Prognostic Significance of HER 2 and HER 4 Coexpression in Childhood Medulloblastoma 1
暂无分享,去创建一个
[1] M. Busslinger,et al. Deregulated expression of PAX 5 in medulloblastoma , 2005 .
[2] V. Schirrmacher,et al. EGF receptor in neoplasia and metastasis , 1993, Cancer and Metastasis Reviews.
[3] W. Gullick,et al. The type I growth factor receptors in human breast cancer , 2004, Breast Cancer Research and Treatment.
[4] E. Jaros,et al. Mitotic percentage index: a new prognostic factor for childhood medulloblastoma. , 1997, European journal of cancer.
[5] I. Ellis,et al. C-erbB-3 in human breast carcinoma: expression and relation to prognosis and established prognostic indicators. , 1996, British Journal of Cancer.
[6] M. Greene,et al. Structural analysis of p185c-neu and epidermal growth factor receptor tyrosine kinases: oligomerization of kinase domains. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[7] L. Akslen,et al. Expression of c-erbB-3 and c-erbB-4 proteins in papillary thyroid carcinomas. , 1996, Cancer research.
[8] H. Gattamaneni,et al. An intensive multiagent chemotherapy regimen for brain tumours occurring in very young children. , 1996, Archives of disease in childhood.
[9] T. van Raaij,et al. Betacellulin activates the epidermal growth factor receptor and erbB-4, and induces cellular response patterns distinct from those stimulated by epidermal growth factor or neuregulin-beta. , 1996, Oncogene.
[10] H Sugimura,et al. Predominant expression of human zic in cerebellar granule cell lineage and medulloblastoma. , 1996, Cancer research.
[11] R. Harkins,et al. Heregulin Activation of Extracellular Acidification in Mammary Carcinoma Cells Is Associated with Expression of HER2 and HER3 (*) , 1995, The Journal of Biological Chemistry.
[12] A. Ullrich,et al. Heregulin‐dependent regulation of HER2/neu oncogenic signaling by heterodimerization with HER3. , 1995, The EMBO journal.
[13] A. Aguzzi,et al. Deregulated expression of PAX5 in medulloblastoma. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[14] M. Kraus,et al. Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas. , 1995, Oncogene.
[15] R. Perry,et al. Prognostic significance of the c-erbB-2 oncogene product in childhood medulloblastoma. , 1995, British Journal of Cancer.
[16] T. Williams,et al. The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[17] T. Hongo,et al. Chromosome analysis of brain tumors in childhood , 1994, Genes, chromosomes & cancer.
[18] P. Mitchell,et al. Cell type-specific regulation of expression of transcription factor AP-2 in neuroectodermal cells. , 1994, Developmental biology.
[19] Y. Yarden,et al. Brain neurons and glial cells express Neu differentiation factor/heregulin: a survival factor for astrocytes. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[20] F. Waldman,et al. Physical mapping of chromosome 17p13.3 in the region of a putative tumor suppressor gene important in medulloblastoma. , 1994, Genomics.
[21] W. Dougall,et al. The neu-oncogene: signal transduction pathways, transformation mechanisms and evolving therapies. , 1994, Oncogene.
[22] L. Cantley,et al. A neu acquaintance for ErbB3 and ErbB4: A role for receptor heterodimerization in growth signaling , 1994, Cell.
[23] Y. Yarden,et al. Neu Differentiation Factors: A Family of Alternatively Spliced Neuronal and Mesenchymal Factors , 1994, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[24] H. Hurst,et al. Transcriptional regulation of the c-erbB-3 gene in human breast carcinoma cell lines. , 1993, Oncogene.
[25] R. Gelber,et al. Prognostic factors in medulloblastoma, including DNA ploidy. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] M. Waterfield,et al. Glial growth factors are alternatively spliced erbB2 ligands expressed in the nervous system , 1993, Nature.
[27] G. Plowman,et al. Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[28] J. Seidman,et al. Expression of the HER‐2/neu proto‐oncogene in serous ovarian neoplasms , 1992, Cancer.
[29] D. Barnes,et al. Expression of the ERBB3 gene product in breast cancer. , 1992, British Journal of Cancer.
[30] I. Ellis,et al. Production and characterization of a polyclonal antibody to the c‐erbB‐3 protein: Examination of c‐erbB‐3 protein expression in adenocarcinomas , 1992, The Journal of pathology.
[31] D. Goeddel,et al. Identification of Heregulin, a Specific Activator of p185erbB2 , 1992, Science.
[32] Yosef Yarden,et al. Isolation of the Neu HER-2 stimulatory ligand: A 44 kd glycoprotein that induces differentiation of mammary tumor cells , 1992, Cell.
[33] J G Klijn,et al. The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patients. , 1992, Endocrine reviews.
[34] A. Ullrich,et al. Mechanistic aspects of the opposing effects of monoclonal antibodies to the ERBB2 receptor on tumor growth. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[35] J. Trent,et al. Suppression of spontaneous melanoma metastasis in scid mice with an antibody to the epidermal growth factor receptor. , 1991, Cancer research.
[36] A. Harris,et al. c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes. , 1991, British Journal of Cancer.
[37] Y. Yarden,et al. Heterodimerization of the erbB-1 and erbB-2 receptors in human breast carcinoma cells: a mechanism for receptor transregulation. , 1990, Biochemistry.
[38] L. Becker,et al. Posterior fossa medulloblastoma in childhood: treatment results and a proposal for a new staging system. , 1990, International journal of radiation oncology, biology, physics.
[39] G. Plowman,et al. Molecular cloning and expression of an additional epidermal growth factor receptor-related gene. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[40] M. Greene,et al. Intermolecular association of the p185 neu protein and EGF receptor modulates EGF receptor function , 1990, Cell.
[41] H. Bloom,et al. Adjuvant chemotherapy for medulloblastoma: the first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I). , 1990, European journal of cancer.
[42] W. Wara,et al. The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone. , 1990, Journal of neurosurgery.
[43] W. McGuire,et al. HER-2/neu oncogene protein and prognosis in breast cancer. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[44] V. Brown,et al. Synergistic interaction of p185c-neu and the EGF receptor leads to transformation of rodent fibroblasts , 1989, Cell.
[45] T. Fleming,et al. Autocrine interaction between TGF alpha and the EGF-receptor: quantitative requirements for induction of the malignant phenotype. , 1989, Oncogene.
[46] M. Sela,et al. Efficacy of antibodies to epidermal growth factor receptor against KB carcinoma in vitro and in nude mice. , 1988, Journal of the National Cancer Institute.
[47] D. Bigner,et al. Structural chromosomal abnormalities in human medulloblastoma. , 1988, Cancer genetics and cytogenetics.
[48] A. Ullrich,et al. Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells , 1987, Cell.
[49] J. Cohen,et al. Stage- and tissue-specific expression of the neu oncogene in rat development. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[50] J. Trent,et al. Epidermal growth factor receptor gene-amplified MDA-468 breast cancer cell line and its nonamplified variants , 1987, Molecular and cellular biology.
[51] R. Weinberg,et al. The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen , 1984, Nature.
[52] J. Minna,et al. Immunohistochemical localization of the immunodominant differentiation antigen lacto-N-fucopentaose III in normal adult and fetal tissues. , 1984, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[53] D.,et al. Regression Models and Life-Tables , 2022 .